4/19/2012

A revision to the Prescription Drug User Fee Act written by Rep. Mike Rogers, R-Mich., changes the FDA's focus from protecting public health and ensuring drug safety and efficacy to enabling "patients to access novel products while promoting economic growth, innovation, competitiveness and job creation among the industries regulated by this Act." Several FDA officials expressed opposition to the expanded mission statement.

Related Summaries